Tag: Evolocumab

Amgen cholesterol injection Repatha reduces heart attack, stroke chances

pharmanewsdaily- March 18, 2017

Amgen cholesterol injection Repatha (evolocumab) has been demonstrated to have cut heart attack and stroke risk by 20% in a phase 3 cardiovascular outcomes study ... Read More